J. Campian

发表

Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma

Christopher A. Miller, D. Marcus, D. Tran, 2018, Neuro-oncology.

Pituitary carcinoma: Two case reports and review of literature

R. Perrin, Lai Xu, K. Rich, 2020, World journal of clinical oncology.

Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology

Sheng-Kwei Song, P. Sun, M. Wallendorf, 2020, Clinical Cancer Research.

Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology

Sheng-Kwei Song, P. Sun, M. Wallendorf, 2019, Clinical Cancer Research.

Diffusion Histology Imaging Detects and Classifies Glioblastoma Pathology Missed by Conventional Magnetic Resonance Imaging

Sheng-Kwei Song, P. Sun, M. Wallendorf, 2019, bioRxiv.

Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy.

D. Hallahan, J. Bradley, J. Michalski, 2018, International journal of radiation oncology, biology, physics.

Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma

E. Leuthardt, J. Dowling, M. Chicoine, 2021, Neuro-oncology advances.

Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base

C. Tsien, M. Chheda, C. Robinson, 2017, Journal of Neuro-Oncology.

Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal Cancers.

D. Hallahan, R. Paniello, W. Thorstad, 2019, JAMA otolaryngology-- head & neck surgery.

Post-operative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers.

D. Hallahan, W. Thorstad, H. Gay, 2018, Oral oncology.

Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives

J. Campian, Ugur Sener, M. Ruff, 2022, International journal of molecular sciences.

The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma

Jingqin Luo, Bilal Hassan, J. Campian, 2021, BMC cancer.

Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy

D. Hallahan, Y. Rao, D. Thotala, 2017, Journal of Neuro-Oncology.

Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma

D. Tran, C. Tsien, A. Lockhart, 2018, Journal of Neuro-Oncology.

Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastoma

E. Leuthardt, R. Strowd, J. D. de Groot, 2022, Neuro-oncology advances.

Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab

Omar H. Butt, E. Leuthardt, Jie Chen, 2022, CNS oncology.

Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastoma

P. Wen, T. Cloughesy, N. Butowski, 2021, Neuro-oncology advances.

A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma

Omar H. Butt, E. Leuthardt, J. Shimony, 2021, Neuro-oncology advances.

Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)

J. Buckner, P. Wen, N. Butowski, 2022, Neuro-oncology advances.

Cytotoxic and mutagenic effects of tobacco-borne free fatty acids.

J. Eaton, W. Mcgregor, J. Campian, 2005, Free radical biology & medicine.

Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas

C. Drake, M. Golightly, J. Karp, 2015, Journal of Neuro-Oncology.

Severe Treatment-Related Lymphopenia in Patients with Newly Diagnosed Rectal Cancer

S. Grossman, X. Ye, J. Campian, 2018, Cancer investigation.

Impact of overall corticosteroid exposure during chemoradiotherapy on lymphopenia and survival of glioblastoma patients

J. Campian, Jiayi Huang, S. Rudra, 2019, Journal of Neuro-Oncology.

Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma.

G. Linette, D. Tran, M. Chicoine, 2015, International journal of radiation oncology, biology, physics.

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Omar H. Butt, Alokkumar Jha, M. Bonnen, 2020, Cancer Cell.

CNS Tumors in Neurofibromatosis.

D. Gutmann, J. Campian, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.

B. Korf, G. Cutter, A. Muzikansky, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Steven R. Abram, T. Mikkelsen, S. Toms, 2022, JAMA oncology.

Generation of oxidants by hypoxic human pulmonary and coronary smooth-muscle cells.

J. Eaton, E. K. Weir, J. Campian, 2008, Chest.

396 NT-I7, a long-acting interleukin-7, promotes expansion of CD8 T cells and NK cells and immune activation in patients with newly diagnosed high-grade gliomas after chemoradiation

Omar H. Butt, N. Le, G. Dunn, 2021, Journal for ImmunoTherapy of Cancer.

Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide

S. Grossman, X. Ye, R. Gress, 2017, Journal of Neuro-Oncology.

Infusion of cryopreserved autologous lymphocytes using a standard peripheral i.v. catheter

D. Gladstone, I. Borrello, J. Campian, 2014, Bone Marrow Transplantation.

Mitochondrial DNA Damage in Iron Overload*

J. Eaton, Xiao-Feng Sun, J. Campian, 2009, Journal of Biological Chemistry.

Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload.

J. Eaton, Xiao-Feng Sun, S. Prabhu, 2010, Free radical biology & medicine.

Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier

E. Leuthardt, J. Shimony, D. Tran, 2016, PloS one.

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.

P. Wen, N. Butowski, M. Mrugala, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry

Kristen M. Naegle, C. Brennan, H. Wakimoto, 2021, JCI insight.

Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma

G. Dunn, S. Dahiya, T. Johanns, 2020, Neuro-oncology advances.

Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study

E. Herzog, Anna R Damato, J. Rubin, 2021, Neuro-oncology advances.

Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.

D. Hallahan, C. Tsien, Deshan Yang, 2018, International journal of radiation oncology, biology, physics.

Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma

J. Campian, F. Gao, Jiayi Huang, 2016, Journal of Neuro-Oncology.

Stem Cell Transfusion Restores Immune Function in Radiation-Induced Lymphopenic C57BL/6 Mice.

D. Hallahan, A. Azab, D. Thotala, 2015, Cancer research.

M. Brock, S. Grossman, X. Ye, 2013, Cancer investigation.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Steven R. Abram, T. Mikkelsen, S. Toms, 2018, Journal of Translational Medicine.

NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Central Nervous System Cancers, Version 3.2020

er, P. Wen, N. Butowski, 2020 .

Association between severe treatment‐related lymphopenia and progression‐free survival in patients with newly diagnosed squamous cell head and neck cancer

S. Grossman, X. Ye, S. Marur, 2014, Head & neck.

Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide

J. Campian, K. Khaddour, N. Harrison, 2020, Case Reports in Oncology.

Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum Investigators

Jennifer S. Yu, E. Leuthardt, Akash J. Patel, 2021, Neurosurgery.

Diagnostic and Therapeutic Strategies for Patients with Malignant Epidural Spinal Cord Compression

J. Campian, D. Patel, 2017, Current Treatment Options in Oncology.

A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma

K. Fink, A. Cohen, J. Boockvar, 2019, Journal of Neuro-Oncology.

A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy

D. Tran, C. Tsien, A. Lockhart, 2016, Journal of Neuro-Oncology.

Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer.

J. Bradley, C. Robinson, M. Roach, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Evaluation of Interim MRI Changes During Limited-Field Radiation Therapy for Glioblastoma and Implications for Treatment Planning.

C. Tsien, L. Henke, J. Campian, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Title : Diffusion Histology Imaging Detects and Classifies Glioblastoma Pathology Missed by Conventional Magnetic Resonance Imaging Running title : Detection and Classification of Glioblastoma Pathology

Sheng-Kwei Song, P. Sun, M. Wallendorf, 2019 .

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.

Susan M. Chang, M. Gilbert, M. Mehta, 2020, Neuro-oncology.

The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma

P. Tran, elliot k fishman, S. Grossman, 2015, American journal of clinical oncology.

Management of chronic lymphocytic leukemia: an update

K. Rai, J. Campian, M. Kaufman, 2009 .

Oxygen Tolerance and Coupling of Mitochondrial Electron Transport*

J. Eaton, J. Campian, Xueshan Gao, 2004, Journal of Biological Chemistry.

Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors.

M. Brock, S. Grossman, X. Ye, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Radiologic Response and Disease Control of Recurrent Intracranial Meningiomas Treated With Reirradiation.

C. Tsien, M. Chicoine, S. Dahiya, 2018, International journal of radiation oncology, biology, physics.

Approach to the patient with radiation necrosis

L. Henke, J. Campian, Jiayi Huang, 2021 .

Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell–Associated Neurotoxicity Syndrome

Omar H. Butt, Gregory F. Wu, B. Ances, 2022, JAMA oncology.

A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)

P. Wen, T. Cloughesy, N. Butowski, 2019, Neuro-oncology.

BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas.

P. Brown, A. Iafrate, D. Cahill, 2021, The New England journal of medicine.

Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma

Christopher A. Miller, E. Mardis, R. Perrin, 2019, Oncoimmunology.

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Steven R. Abram, T. Mikkelsen, S. Toms, 2018, Journal of Translational Medicine.

Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer

Bilal Hassan, J. Campian, Cynthia X. Ma, 2019, Breast Cancer Research and Treatment.

278O Preliminary results of a phase II study of retifanlimab (PD-1 inhibitor) plus or minus epacadostat (IDO1 inhibitor) in combination with bevacizumab and hypofractionated radiotherapy for recurrent glioblastoma: NCT03532295

R. Strowd, M. Chheda, T. Johanns, 2022, Annals of Oncology.

Long-acting recombinant human interleukin-7, NT-I7, increases cytotoxic CD8+ T cells and enhances survival in mouse glioma models.

D. Hallahan, Se-Hwan Yang, M. Chheda, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical Outcomes of Small Cell Glioblastoma or Glioblastoma With Oligodendroglioma Component Treated With Radiation Therapy and Temozolomide

D. Tran, M. Chicoine, G. Dunn, 2014 .

Clinical, Histological and Molecular Features of Gliomas in Adults with Neurofibromatosis Type 1.

I. Mellinghoff, D. Gutmann, S. Dahiya, 2023, Neuro-Oncology.

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma

Michael Fisher, B. Korf, J. Tonsgard, 2023, Neuro-oncology.

CTIM-10. A PHASE II STUDY OF RETIFANLIMAB (PD-1 INHIBITOR) IN COMBINATION WITH BEVACIZUMAB AND HYPOFRACTIONATED RADIOTHERAPY FOR RECURRENT GLIOBLASTOMA: NCT03532295

Omar H. Butt, Y. Tao, R. Strowd, 2022, Neuro-Oncology.

Proton craniospinal irradiation with bevacizumab and pembrolizumab for leptomeningeal disease: a case report

J. Campian, K. Leventakos, N. Laack, 2023, CNS oncology.

A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.

Omar H. Butt, Y. Tao, E. Herzog, 2022, Neuro-Oncology Practice.

Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide

S. Grossman, X. Ye, R. Gress, 2017, Journal of Neuro-Oncology.

A phase I/II study to evaluate the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy: The interim result of the phase I data.

N. Le, G. Dunn, M. Chheda, 2021 .